FT Partner Content
@ft_content
Followers
22K
Following
1
Media
349
Statuses
2K
Financial Times Partner Content helps brands tell powerful stories that are relevant to our audience
London
Joined September 2016
FT Partner Content: Creating branded content that engages and delights. Learn more
60
44
216
America's new tariff strategy and its impact on the economy . Part of our FT Transact series with @UBS . Watch the full video now
0
0
0
The city-state where investment in AI, quantum computing and other tech attracts global businesses. Learn More:
0
1
1
Early on-set dementia is misdiagnosed in young people. Paul Little (CEO of Vesper Bio) on the new episode of The Next Five featuring Dr. Ann Beliën (@Rejuven8Biomed) and Gianmario Verona (@humantechnopole). Listen - Partner Content by Yes Milano
1
0
2
New money? Modernisation of banking systems allows the customer experience to improve. Learn more:
1
0
1
Automation provides a solution, and by consolidating and integrating the technology landscape, teams can reduce their overhead and extend their competitive edge. So, what’s stopping them?. Learn more:
7
3
7
From production to consumption and end-of-life, beverage cartons can help to improve food safety while cutting food waste. Learn more:
0
2
2
Tired of monotonous tasks? AI agents are transforming work, collaborating across business functions to streamline operations and boost productivity. Learn more:
0
1
0
COVID-19 proved healthcare requires better collaboration. Gianmario Verona (President, @humantechnopole) on the new episode of The Next Five featuring Dr. Ann Beliën (@Rejuven8Biomed) and Paul Little (Vesper Bio). Listen - Partner Content by Yes Milano
0
0
2
Now that cryptocurrencies are becoming more established, novel offerings are giving investors greater choice and control over their assets. Learn more:
1
1
1
Brain cells don't regenerate, so losing them ages you faster. Paul Little (CEO, Vesper Bio) on The Next Five ft. Dr. Ann Beliën (Founder & CEO, @Rejuven8Biomed) & Gianmario Verona (President, @humantechnopole). Listen - Partner Content by Yes Milano
1
0
4
Heard the new episode of The Next Five? Gain insight into the future of biotech, courtesy of Dr. Ann Beliën (@Rejuven8Biomed), Paul Little (Vesper Bio) and Gianmario Verona (@humantechnopole). Listen here - Partner Content by Yes Milano
1
1
2
Institutional investors have long been cautious of crypto assets. Is change finally on the horizon?. Learn more:
2
0
2
How COVID-19 fundamentally altered the Biotech funding landscape. Dr. Ann Beliën (Founder & CEO, Rejuvenate Biomed) on The Next Five. Apple: . Spotify: FT: Partner Content by Yes Milano
0
0
0
How an innovative sub-nano membrane can drastically reduce industrial separation costs. Learn more:
0
2
1
Biotech is in the midst of a Malthusian funding crisis. Paul Little (CEO of Vesper Bio) on new episode of The Next Five. Listen here below -. Apple: . Spotify: FT: Partner Content by Yes Milano
1
1
0
The UK's grid needs an upgrade – but what are the regulatory implications?. Learn more:
0
2
0
New 'The Next Five' ft. Dr. Ann Beliën (Founder & CEO, @Rejuven8Biomed), Paul Little (CEO, Vesper Bio) & Gianmario Verona (President, @humantechnopole). Apple: . Spotify: FT: Partner Content by Yes Milano
0
2
2
Moutai: why China’s unique national spirit is a pure distillation of nature, patience and skill. Learn more:
0
1
1
Institutional investors have long been cautious of crypto assets. Is change finally on the horizon?. Learn more:
0
1
1
AI is increasingly being deployed to fight wildfires. But with high costs and limited prevention funding, can technology really turn the tide?. Watch more: Part of our Rethink Series
0
2
1